Nanobiotix (NBTX) Non-Current Debt: 2019-2024

Historic Non-Current Debt for Nanobiotix (NBTX) over the last 5 years, with Dec 2024 value amounting to $49.1 million.

  • Nanobiotix's Non-Current Debt rose 10.68% to $52.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $52.6 million, marking a year-over-year increase of 10.68%. This contributed to the annual value of $49.1 million for FY2024, which is 0.27% down from last year.
  • Per Nanobiotix's latest filing, its Non-Current Debt stood at $49.1 million for FY2024, which was down 0.27% from $49.3 million recorded in FY2023.
  • In the past 5 years, Nanobiotix's Non-Current Debt ranged from a high of $50.4 million in FY2020 and a low of $44.8 million during FY2021.
  • Over the past 2 years, Nanobiotix's median Non-Current Debt value was $49.2 million (recorded in 2023), while the average stood at $49.2 million.
  • Its Non-Current Debt has fluctuated over the past 5 years, first rose by 3.53% in 2020, then declined by 11.14% in 2021.
  • Nanobiotix's Non-Current Debt (Yearly) stood at $50.4 million in 2020, then declined by 11.14% to $44.8 million in 2021, then reached $49.3 million in 2023, then declined by 0.27% to $49.1 million in 2024.